ACADIA PHARMACEUTICALS INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $627.0M | $326.0M |
| FY2021 | — | $540.9M | $147.4M |
| FY2022 | — | $400.4M | $114.8M |
| FY2023 | — | $431.8M | $188.7M |
| FY2024 | — | $732.8M | $319.6M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $627.0M | $326.0M |
| FY2021 | — | $540.9M | $147.4M |
| FY2022 | — | $400.4M | $114.8M |
| FY2023 | — | $431.8M | $188.7M |
| FY2024 | — | $732.8M | $319.6M |